Enanta Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
5 Top Performing Stocks Of The Best ETF Of 1H2018
Article By: Sweta Killa Saturday, June 30, 2018 6:20 PM EDT
PowerShares S&P SmallCap Healthcare Fund PSCH​ topped the list of best performing equity ETFs of the first half of 2018, with impressive returns of about 30.6%. The rally was mainly driven by tax reform, rising M&A and positive regulatory backdrop.
In this article: PSCH, TCMD, RGNX, ENTA, TRHC, SRDX
Enanta Pharmaceuticals - Chart Of The Day
Article By: Jim Van Meerten Friday, January 26, 2018 4:33 PM EDT
Since the Trend Spotter signaled a buy on 12/13 the stock gained 44.83%.
In this article: ENTA
4 Drug Stocks In Focus This World Hepatitis Day
Article By: Arpita Dutt Friday, July 28, 2017 10:45 AM EDT
The HCV market will continue to face challenges as more treatments enter the market resulting in increased competition and additional pricing pressure. In fact, HCV drugs have faced immense scrutiny due to their high prices.
In this article: GILD, MRK, ABBV, ENTA
AbbVie/Enanta Post Stellar Phase 3 Data But No One Is Cheering
Article By: Lorimer Wilson Friday, April 21, 2017 2:54 AM EDT
AbbVie Inc. and its partner Enanta Pharmaceuticals, Inc. received exceedingly good news about new Phase III data but since these drugs first went into combo clinical trials, the market has peaked and begun a painful retreat.
In this article: ABBV, ENTA Also: MRK, GILD
5 Biotech Stocks To Watch As Interest In NASH Increases
Article By: Arpita Dutt Thursday, September 22, 2016 1:45 PM EDT
The market is suddenly abuzz about nonalcoholic steatohepatitis or NASH, a common but often “silent” liver disease. Several companies are working on developing treatments for NASH – the market could be worth billions of dollars.
In this article: ICPT, CNAT, GALT, ENTA, GLMD Also: AGN
2 Hot Biotechs Set To Deliver Paydays To Investors In 2015
Article By: Bret Jensen Saturday, January 31, 2015 9:50 PM EDT
Small cap biotech stocks have been holding up well despite being in a notoriously volatile sector.
Active Stocks: MELA, SGYP, OMER, NVS, ENTA
Article By: BioMedReports Tuesday, October 21, 2014 6:09 PM EDT
U.S. stocks rallied on Tuesday, with the S&P 500 on track for a fourth straight session of gains boosted by strong corporate results, including Apple's.
In this article: NVS, SGYP, OMER, MELA, ENTA
1 to 7 of 7 Posts